StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Valeant (VRX) PT Cut to $11 at Mizuho
June 8, 2016 2:23 PM
Mizuho Securities analyst Irina Koffler reiterated an Underperform rating on Valeant Pharmaceuticals (NYSE: VRX) and cut her price target to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Hot Comments
Next Articles
UPDATE: Valeant's (VRX) Plaque Psoriasis Injection Faces July 19th FDA Panel
June 9, 2016 9:14 AM
BTIG Sees Valeant's (VRX) Growth Plan Taking Longer than Expected to Implement; Affirms at 'Neutral' (WBA)
June 8, 2016 2:06 PM
Valeant (VRX) Said Near Agreement on Asset Sales - Source
June 8, 2016 1:40 PM
